Sato T, Maekawa M, Mano N, Abe T, Yamaguchi H. Role of OATP4C1 in Renal Handling of Remdesivir and its Nucleoside Analog GS-441524: The First Approved Drug for Patients with COVID-19. J Pharm Pharm Sci [Internet]. 2021 May 15 [cited 2025 Dec. 21];24:227-36. Available from: https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/31813